| Product NDC: | 0187-2207 | 
| Proprietary Name: | CeraVe | 
| Non Proprietary Name: | Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone | 
| Active Ingredient(s): | 4.23; 21.15; 7.05; 14.1; 8.46 g/141g; g/141g; g/141g; g/141g; g/141g & nbsp; Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone | 
| Administration Route(s): | TOPICAL | 
| Dosage Form(s): | SPRAY | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0187-2207 | 
| Labeler Name: | Valeant Pharmaceuticals North America LLC | 
| Product Type: | HUMAN OTC DRUG | 
| FDA Application Number: | part352 | 
| Marketing Category: | OTC MONOGRAPH FINAL | 
| Start Marketing Date: | 20121128 | 
| Package NDC: | 0187-2207-01 | 
| Package Description: | 141 g in 1 TUBE (0187-2207-01) | 
| NDC Code | 0187-2207-01 | 
| Proprietary Name | CeraVe | 
| Package Description | 141 g in 1 TUBE (0187-2207-01) | 
| Product NDC | 0187-2207 | 
| Product Type Name | HUMAN OTC DRUG | 
| Non Proprietary Name | Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone | 
| Dosage Form Name | SPRAY | 
| Route Name | TOPICAL | 
| Start Marketing Date | 20121128 | 
| Marketing Category Name | OTC MONOGRAPH FINAL | 
| Labeler Name | Valeant Pharmaceuticals North America LLC | 
| Substance Name | AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE | 
| Strength Number | 4.23; 21.15; 7.05; 14.1; 8.46 | 
| Strength Unit | g/141g; g/141g; g/141g; g/141g; g/141g | 
| Pharmaceutical Classes |